Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Biocryst Pharmaceuticals buy Royal Bank of Canada

Biocryst Pharmaceuticals
Start price
€6.95
25.09.23 / 50%
Target price
€9.44
25.09.24
Performance (%)
-2.42%
End price
€6.78
26.09.24
Summary
This prediction ended on 26.09.24 with a price of €6.78. With a performance of -2.42%, the BUY prediction by Royal_Bank_of_Canada finished with a loss. Royal_Bank_of_Canada has a follow-up prediction for Biocryst Pharmaceuticals where he still thinks Biocryst Pharmaceuticals is a Buy. Royal_Bank_of_Canada has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Biocryst Pharmaceuticals 10.197% 10.197% 28.877%
iShares Core DAX® 1,77 % 3,45 % 5,56 %
iShares Nasdaq 100 -3,50 % 1,61 % 32,31 %
iShares Nikkei 225® -4,94 % 4,22 % 57,83 %
iShares S&P 500 0,30 % 2,58 % 24,81 %

Comments by Royal_Bank_of_Canada for this prediction

In the thread Biocryst Pharmaceuticals diskutieren
Prediction Buy
Perf. (%) -2.42%
Target price 9.437
Change
Ends at 25.09.24

BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $10.00 price target on the stock.
Ratings data for BCRX provided by MarketBeat

Royal Bank of Canada 
0
Report Share
25.09.23
In the thread Trading Biocryst Pharmaceuticals
Prediction Buy
Perf. (%) -2.42%
Target price 9.437
Change
Ends at 25.09.24

Die von Royal_Bank_of_Canada gewählte maximale Laufzeit wurde überschritten

Royal Bank of Canada 
0
Report Share
26.09.24

Current prediction by Royal_Bank_of_Canada for Biocryst Pharmaceuticals

buy
Biocryst Pharmaceuticals

Start price
Target price
Perf. (%)
€5.59
30.01.26
€10.92
30.01.27
72.57%
07.07.26

Royal Bank of Canada 
30.01.26 50%

Stopped prediction by Royal_Bank_of_Canada for Biocryst Pharmaceuticals

buy
Biocryst Pharmaceuticals

Start price
Target price
Perf. (%)
€9.52
07.07.26
€12.24
07.07.27
1.24%
07.07.26

Royal Bank of Canada 
07.07.26 50%
buy
Biocryst Pharmaceuticals

Start price
Target price
Perf. (%)
€7.60
30.06.25
€11.09
30.06.26
14.00%
01.07.26

Royal Bank of Canada 
30.06.25 50%
buy
Biocryst Pharmaceuticals

Start price
Target price
Perf. (%)
€8.90
06.05.25
€11.51
06.05.26
-16.23%
07.05.26

Royal Bank of Canada 
06.05.25 50%
buy
Biocryst Pharmaceuticals

Start price
Target price
Perf. (%)
€5.91
11.04.25
€9.75
11.04.26
39.83%
12.04.26

Royal Bank of Canada 
11.04.25 50%
buy
Biocryst Pharmaceuticals

Start price
Target price
Perf. (%)
€7.79
25.02.25
€10.47
25.02.26
-19.06%
26.02.26

Royal Bank of Canada 
25.02.25 50%
buy
Biocryst Pharmaceuticals

Start price
Target price
Perf. (%)
€6.61
05.11.24
€9.16
05.11.25
-6.99%
06.11.25

Royal Bank of Canada 
05.11.24 50%